BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25303053)

  • 1. Metastatic cancer-related thrombotic microangiopathies: a cohort study.
    Ducos G; Mariotte E; Galicier L; Canet E; Boutboul D; Lemiale V; Schlemmer B; Veyradier A; Azoulay E; Zafrani L
    Future Oncol; 2014 Aug; 10(10):1727-34. PubMed ID: 25303053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer awareness in atypical thrombotic microangiopathies.
    Oberic L; Buffet M; Schwarzinger M; Veyradier A; Clabault K; Malot S; Schleinitz N; Valla D; Galicier L; Bengrine-Lefèvre L; Gorin NC; Coppo P;
    Oncologist; 2009 Aug; 14(8):769-79. PubMed ID: 19684072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic microangiopathies (TTP, HUS, HELLP).
    Kappler S; Ronan-Bentle S; Graham A
    Emerg Med Clin North Am; 2014 Aug; 32(3):649-71. PubMed ID: 25060255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of thrombotic microangiopathies in multiple myeloma.
    Portuguese AJ; Gleber C; Passero FC; Lipe B
    Leuk Res; 2019 Oct; 85():106195. PubMed ID: 31404728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic transplant-associated thrombotic microangiopathy: case report and review of diagnosis and treatments.
    Chapin J; Shore T; Forsberg P; Desman G; Van Besien K; Laurence J
    Clin Adv Hematol Oncol; 2014 Sep; 12(9):565-73. PubMed ID: 25654478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic and therapeutic guidelines of thrombotic microangiopathies of the Spanish Apheresis Group].
    Contreras E; de la Rubia J; Del Río-Garma J; Díaz-Ricart M; García-Gala JM; Lozano M;
    Med Clin (Barc); 2015 Apr; 144(7):331.e1-331.e13. PubMed ID: 25433791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Human immunodeficiency virus-associated thrombotic microangiopathies].
    Gilardin L; Malak S; Schoindre Y; Galicier L; Veyradier A; Coppo P
    Rev Med Interne; 2012 May; 33(5):259-64. PubMed ID: 22280852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombotic microangiopathy: when time is the key factor!].
    Hemett OM; Martins F; Descombes E; Betticher D; Hayoz D
    Rev Med Suisse; 2014 Apr; 10(425):794, 796-803. PubMed ID: 24791425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analyses of data of patients with Thrombotic Microangiopathy in the WAA registry.
    Mörtzell M; Berlin G; Nilsson T; Axelsson CG; Efvergren M; Audzijoni J; Griskevicius A; Ptak J; Blaha M; Tomsova H; Liumbruno GM; Centoni P; Newman E; Eloot S; Dhondt A; Tomaz J; Witt V; Rock G; Stegmayr B
    Transfus Apher Sci; 2011 Oct; 45(2):125-31. PubMed ID: 21903476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of thrombotic microangiopathy.
    Thompson GL; Kavanagh D
    Int J Lab Hematol; 2022 Sep; 44 Suppl 1(Suppl 1):101-113. PubMed ID: 36074708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-traumatic thrombotic microangiopathy: What trauma surgeons need to know?
    Hossain MA; Ahmed N; Gupta V; Bajwa R; Alidoost M; Asif A; Vachharajani T
    Chin J Traumatol; 2021 Mar; 24(2):69-74. PubMed ID: 33518399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies.
    Fuchs TA; Kremer Hovinga JA; Schatzberg D; Wagner DD; Lämmle B
    Blood; 2012 Aug; 120(6):1157-64. PubMed ID: 22611154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemolysis and schistocytosis in the emergency department: consider pseudothrombotic microangiopathy related to vitamin B12 deficiency.
    Noël N; Maigné G; Tertian G; Anguel N; Monnet X; Michot JM; Goujard C; Lambotte O
    QJM; 2013 Nov; 106(11):1017-22. PubMed ID: 23842487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gallbladder cancer-associated thrombotic microangiopathy.
    Gonsalves WI; Gupta V; Smeltzer JP; Singh PP; McWilliams RR; Gangat N
    Future Oncol; 2013 Nov; 9(11):1711-5. PubMed ID: 24156330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thrombotic microangiopathies].
    Moulinier C; Veyradier A; Rondeau E; Coppo P;
    Rev Prat; 2013 Feb; 63(2):163-70. PubMed ID: 23513771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary tumor thrombotic microangiopathy: report of 3 cases and review of the literature.
    Gainza E; Fernández S; Martínez D; Castro P; Bosch X; Ramírez J; Pereira A; Cibeira MT; Esteve J; Nicolás JM
    Medicine (Baltimore); 2014 Nov; 93(24):359-363. PubMed ID: 25500705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma exchange therapy for thrombotic microangiopathies.
    Nguyen TC; Han YY
    Organogenesis; 2011; 7(1):28-31. PubMed ID: 21293177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism-mediated thrombotic microangiopathy and B12.
    Goubran H; Ragab G; Sabry W
    Vitam Horm; 2022; 119():441-455. PubMed ID: 35337630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic microangiopathy and occult neoplasia.
    Pirrotta MT; Bucalossi A
    Cardiovasc Hematol Disord Drug Targets; 2010 Jun; 10(2):87-93. PubMed ID: 20397971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fulminant thrombotic microangiopathy as a clinical presentation of an occult signet-ring cell carcinoma of the lung and misdiagnosed as idiopathic thrombotic thrombocytopenic purpura.
    Niscola P; Palmieri MB; Scaramucci L; Vischini G; Giovannini M; Ferrannini M; Palumbo R; Fratoni S
    Saudi Med J; 2010 May; 31(5):581. PubMed ID: 20464054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.